Trans Tasman Radiation Oncology Group   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Waratah Australia (1989)

Organization Overview

First Clinical Trial
2000
NCT00115700
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Trans Tasman Radiation Oncology Group | Trans-Tasman Radiation Oncology Group (TROG) | TROG- Trans Tasman Radiation Oncology Group